Why the study?
Venous thromboembolic disease is often a chronic, recurrent condition requiring varying durations of secondary thromboprophylaxis based on individual risks of recurrence and bleeding.
Does long-term anticoagulation therapy prevent VTE recurrence in patients following deep vein thrombosis?
Does long-term anticoagulation therapy prevent VTE recurrence in patients following deep vein thrombosis?
Secondary thromboprophylaxis should last at least 3 months, with extended therapy recommended for patients with high recurrence risk and low bleeding risk.
Answers are grounded in this paper and cite their sources.
May guide extended anticoagulation in select high-risk VTE patients; leaves open randomized confirmation before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Dalibor Musil (2020) conducted a review in Deep vein thrombosis and venous thromboembolism. Long-term anticoagulation therapy vs. Short-term therapy or no therapy was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: